Patents by Inventor Alistair Forrest

Alistair Forrest has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9353370
    Abstract: The present invention provides (a) a functional nucleic acid molecule comprises: a target determinant sequence comprising antisense sequence to a target sequence in the protein-encoding RNA for which protein synthesis efficiency is to be increased and a regulatory sequence having an activity of increasing of the protein synthesis efficiency, and (b) a use of the functional nucleic acid molecule.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: May 31, 2016
    Assignees: Riken, International School for Advanced Studies
    Inventors: Piero Carninci, Alistair Forrest, Stefano Gustincich, Claudia Carrieri, Silvia Zucchelli
  • Patent number: 9156900
    Abstract: The present invention aims to provide a novel undifferentiated state-control agent that maintains and/or improves an undifferentiated state of undifferentiated cells. CCL2 or a protein containing a functional domain thereof is used as the undifferentiated state-control agent. By culturing undifferentiated cells in the presence of the control agent, it is possible to maintain and/or improve an undifferentiated state of the undifferentiated cells. Examples of the undifferentiated cells include embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells). The origin of the cells is not particularly limited, and may be a human, mouse, or the like, for example.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: October 13, 2015
    Assignee: RIKEN
    Inventors: Harukazu Suzuki, Yuki Hasegawa, Alistair Forrest
  • Publication number: 20140107187
    Abstract: The present invention provides (a) a functional nucleic acid molecule comprises: a target determinant sequence comprising antisense sequence to a target sequence in the protein-encoding RNA for which protein synthesis efficiency is to be increased and a regulatory sequence having an activity of increasing of the protein synthesis efficiency, and (b) a use of the functional nucleic acid molecule.
    Type: Application
    Filed: March 30, 2012
    Publication date: April 17, 2014
    Applicants: INTERNATIONAL SCHOOL FOR ADVANCED STUDIES, RIKEN
    Inventors: Piero Carninci, Alistair Forrest, Stefano Gustincich, Claudia Carrieri, Silvia Zucchelli
  • Publication number: 20140017790
    Abstract: The present invention aims to provide a novel undifferentiated state-control agent that maintains and/or improves an undifferentiated state of undifferentiated cells. CCL2 or a protein containing a functional domain thereof is used as the undifferentiated state-control agent. By culturing undifferentiated cells in the presence of the control agent, it is possible to maintain and/or improve an undifferentiated state of the undifferentiated cells. Examples of the undifferentiated cells include embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells). The origin of the cells is not particularly limited, and may be a human, mouse, or the like, for example.
    Type: Application
    Filed: March 30, 2012
    Publication date: January 16, 2014
    Applicant: RIKEN
    Inventors: Harukazu Suzuki, Yuki Hasegawa, Alistair Forrest